Barbara Plaimauer
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 10, 2022
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
Journal: Haematologica
Published: October 26, 2021
Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 26, 2019
Temperature-dependent irreversible conformational change of recombinant ADAMTS13 upon metal ion chelation.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 23, 2018
Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 16, 2017
N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura.
Journal: Blood
Published: September 08, 2016
Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 23, 2015
ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.
Journal: Blood
Published: August 07, 2015
Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 05, 2015
Neutralization of inhibitory antibodies and restoration of therapeutic ADAMTS-13 activity levels in inhibitor-treated rats by the use of defined doses of recombinant ADAMTS-13.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 22, 2015
A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 22, 2014
Last Updated: 09/26/2026